Table 1 Baseline demographic and clinical characteristics of the enrolled patients (n = 39).
| Variable | Placebo (SD) | BoNT‐A (SD) |
|---|---|---|
| No of patients | 19 | 20 |
| Women (no of patients) | 7 | 10 |
| Mean age (years) | 45.63 (7.90) | 47.60 (11.24) |
| Mean duration of illness (years) | 9.13 (9.90) | 7.38 (6.22) |
| Simple/complex (no of patients) | 6/13 | 7/13 |
| VAS handwriting | 1.78 (1.39) | 1.70 (1.20) |
| Symptom severity scale (points) | 27.32 (4.57) | 28.10 (4.67) |
| Functional status scale (points) | 8.95 (5.41) | 10.25 (7.02) |
| Writer's cramp rating scale (points) | 4.47 (1.84) | 4.50 (1.96) |
| Writing speed (lines/2 min) | 7.93 (3.20) | 7.59 (2.80) |
BoNT‐A, botulinum toxin type A; VAS, visual analogue scale.